Microbiology Network, Inc.

microbiol.org

The Microbiology Network provides a network of subject matter experts for consulting, training and expert witness services to industry. Our focus is GMP and contamination control. All of our resource consultants are successful, proven and experienced consultants with expertise in:QC microbiology - contamination control, environmental monitoring, cleaning/sanitization validation and lab audit and operation.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

BIOSERO COLLABORATES WITH ARACELI BIOSCIENCES FOR HIGH-CONTENT ANALYSIS

Biosero, Inc. | February 02, 2022

news image

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, announced a collaboration with Araceli Biosciences that will allow scientists to integrate Araceli’s Endeavor™ high-speed imaging platform into automated workflows controlled by Biosero’s Green Button Go® software suite. The Endeavor platform offers extremely rapid imaging for high-content analysis projects. In just minutes, the instrument can provide subcellula...

Read More

Pharmacy Market

VINCERX PHARMA ANNOUNCES FDA CLEARANCE OF IND FOR VIP943

Globenewswire | August 23, 2023

news image

Vincerx Pharma, Inc. a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today reported that it has received clearance for its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for VIP943. Vincerx expects to enroll the first patient in the study early in the fourth quarter of 2023. "The IND clearance by the FDA is...

Read More

Pharmacy Market

MALLAX ACQUIRES SANA PHARMA MEDICAL, ESTABLISHING A NEW NORDIC PHARMACEUTICAL PLATFORM

Mallax | July 05, 2021

news image

Mallax Pharmaceuticals AB has acquired Sana Pharma Medical AS, forming a new Nordic pharmaceutical platform. SPM, founded in Norway in 2014, is a rapidly growing OTC company with complete pharmaceutical infrastructure and Nordic distribution coverage. With the well-established brands such as Lunixen and Sedix and additional products based on the chemical melatonin, the Company has a leading position in the fast-growing sleep and anxiety sector. SPM is a well-resourced platform wit...

Read More

Business Insights, PHARMACY MARKET

ENVISION PHARMA GROUP ANNOUNCES ACQUISITION OF OKRA.AI

Envision Pharma Group | February 10, 2023

news image

Envision Pharma Group (Envision), a leading evidence-based communication services and industry-leading technology solutions provider serving biotech, pharmaceutical, and medical device companies recently announced the acquisition of OKRA.ai, a leading technology company active in the development of artificial intelligence (AI) solutions for commercialization, medical, real-world evidence and data analytics, and pricing for the life sciences and pharmaceutical industries. OKRA.ai...

Read More
news image

Business Insights

BIOSERO COLLABORATES WITH ARACELI BIOSCIENCES FOR HIGH-CONTENT ANALYSIS

Biosero, Inc. | February 02, 2022

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, announced a collaboration with Araceli Biosciences that will allow scientists to integrate Araceli’s Endeavor™ high-speed imaging platform into automated workflows controlled by Biosero’s Green Button Go® software suite. The Endeavor platform offers extremely rapid imaging for high-content analysis projects. In just minutes, the instrument can provide subcellula...

Read More
news image

Pharmacy Market

VINCERX PHARMA ANNOUNCES FDA CLEARANCE OF IND FOR VIP943

Globenewswire | August 23, 2023

Vincerx Pharma, Inc. a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today reported that it has received clearance for its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical trial for VIP943. Vincerx expects to enroll the first patient in the study early in the fourth quarter of 2023. "The IND clearance by the FDA is...

Read More
news image

Pharmacy Market

MALLAX ACQUIRES SANA PHARMA MEDICAL, ESTABLISHING A NEW NORDIC PHARMACEUTICAL PLATFORM

Mallax | July 05, 2021

Mallax Pharmaceuticals AB has acquired Sana Pharma Medical AS, forming a new Nordic pharmaceutical platform. SPM, founded in Norway in 2014, is a rapidly growing OTC company with complete pharmaceutical infrastructure and Nordic distribution coverage. With the well-established brands such as Lunixen and Sedix and additional products based on the chemical melatonin, the Company has a leading position in the fast-growing sleep and anxiety sector. SPM is a well-resourced platform wit...

Read More
news image

Business Insights, PHARMACY MARKET

ENVISION PHARMA GROUP ANNOUNCES ACQUISITION OF OKRA.AI

Envision Pharma Group | February 10, 2023

Envision Pharma Group (Envision), a leading evidence-based communication services and industry-leading technology solutions provider serving biotech, pharmaceutical, and medical device companies recently announced the acquisition of OKRA.ai, a leading technology company active in the development of artificial intelligence (AI) solutions for commercialization, medical, real-world evidence and data analytics, and pricing for the life sciences and pharmaceutical industries. OKRA.ai...

Read More